U.S. markets closed

CVS Health Corporation (CVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
84.58-0.93 (-1.09%)
At close: 4:00PM EDT
84.24 -0.34 (-0.40%)
After hours: 07:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close85.51
Open84.63
Bid84.40 x 1300
Ask84.58 x 900
Day's Range83.57 - 85.44
52 Week Range55.36 - 90.61
Volume5,336,971
Avg. Volume5,345,253
Market Cap111.609B
Beta (5Y Monthly)0.82
PE Ratio (TTM)15.48
EPS (TTM)5.46
Earnings DateNov 04, 2021 - Nov 08, 2021
Forward Dividend & Yield2.00 (2.34%)
Ex-Dividend DateJul 22, 2021
1y Target Est96.11
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-10% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CVS Health Corporation
    Large Cap US Pick List - September 2021This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
    Rating
    Fair Value
    Economic Moat
    15 days agoMorningstar
View more
  • Zacks

    CVS Health (CVS) Stock Moves -1.09%: What You Should Know

    In the latest trading session, CVS Health (CVS) closed at $84.58, marking a -1.09% move from the previous day.

  • Motley Fool

    5 at 5: Your Daily Digest for Real Estate Investing, 9/20/21

    CVS Health (NYSE: CVS), one of the biggest U.S. providers of COVID-19 tests and vaccines, plans to hire 25,000 people this week, if it can, to address staffing shortages that have seen some customers seeking shots turned away, says this Wall Street Journal piece [subscription required]. The Millionacres takeaway: The nation's biggest drugstore chain is a mainstay in many a commercial real estate portfolio, so foot traffic there is good from that perspective.

  • TheStreet.com

    CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

    CVS Health on Monday said it planned to hire 25,000 clinical and retail employees to prepare for a potential surge in demand during the flu season as coronavirus-related vaccine shots and testing continue to rise. "Every flu season we need additional team members, but this year we're looking for even more," Neela Montgomery, president of CVS Pharmacy and executive vice president of the parent, said in a statement. "With the continued presence of Covid-19 in our communities, we're estimating a much greater need for pharmacists, trained pharmacy technicians, nurses, and retail store associates," Montgomery said.